Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/13/2003CA2086131C Anti-human ige monoclonal antibodies
05/12/2003WO2002034943A1 Method of quantifying genetic modification and standard molecule to be used therein
05/09/2003CA2411537A1 Gene detecting method and test kit
05/09/2003CA2411476A1 Functional assay for agonist activation of receptors
05/09/2003CA2406687A1 Chimeric promoters for controlling expression in muscle cells
05/09/2003CA2361788A1 Enzyme or cell preparation with inulinase activity
05/08/2003WO2003038724A2 Methods and apparatus for protein sequence analysis
05/08/2003WO2003038436A2 Microfluidic ser(r)s detection
05/08/2003WO2003038130A2 Therapeutics and diagnostics for disorders of erythropoiesis
05/08/2003WO2003038126A1 Probe beads for affinity reaction and detection system
05/08/2003WO2003038124A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038121A2 Method for the detection of cytosine methylation in immobilised dna samples
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor
05/08/2003WO2003038104A1 Methods for genetically modifying a target population of an organism
05/08/2003WO2003038103A1 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
05/08/2003WO2003038102A1 A promoter for transformation of monocot plants
05/08/2003WO2003038101A1 Gene expression
05/08/2003WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications
05/08/2003WO2003038099A2 Regulation of gene transcription by the variable number of tandem repeats (vntr) domain of the dopamine transporter gene
05/08/2003WO2003038098A2 5t4 ligand
05/08/2003WO2003038097A1 Ubiquitin-specific protease occurring in the brain and dna encoding the same
05/08/2003WO2003038096A1 Receptor for angiogenesis inhibitor and method of screening angiogenesis inhibitor
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003038094A1 Regulation of human glucose transporter
05/08/2003WO2003038093A2 Regulation of human l-serine dehydratase
05/08/2003WO2003038092A1 Method for identifying transport proteins
05/08/2003WO2003038091A1 Oligonucleotide sequences free from mishybridization and method of designing the same
05/08/2003WO2003038089A1 Probe solutin compositions, reactive chip using the same and process for the production thereof
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038087A1 DR5 GENE PROMOTER AND Siah-1 GENE PROMOTER
05/08/2003WO2003038086A1 Soft ionization device and applications thereof
05/08/2003WO2003038083A1 Regulation of human type i adenylate cyclase
05/08/2003WO2003038082A2 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
05/08/2003WO2003038079A2 A mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
05/08/2003WO2003038071A1 Detection of haematopoietic stem cells and progeny and uses thereof
05/08/2003WO2003038067A1 Fungal micro-organism having an increased ability to carry out biotechnological process(es)
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038050A2 Antisense modulation of phospholipase a2 group v expression
05/08/2003WO2003038049A2 Method for isolating cell-type specific mrnas
05/08/2003WO2003038044A2 DNA POLYMERASE ETA (POLη) CDNA AND USES THEREOF
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038041A2 Il-4 mutein proteins, antibodies, compositions, methods and uses
05/08/2003WO2003038039A2 Novel cell-based assays for g-protein-coupled receptor-mediated activities
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003037932A2 Human coagulation factor vii polypeptides
05/08/2003WO2003037930A1 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same
05/08/2003WO2003037927A1 Novel protein, its dna and use thereof
05/08/2003WO2003037926A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/08/2003WO2003037924A1 Aequorin as a reporter gene in yeast
05/08/2003WO2003037923A1 Aequorin as a growth marker in yeast
05/08/2003WO2003037922A1 Analgesic antitumor peptide from scorpion and method of producing it
05/08/2003WO2003037919A2 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof
05/08/2003WO2003037918A2 Pyranosone dehydratase from phanerochaete chrysosporium
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037909A1 Acyclic linker-containing oligonucleotides and uses thereof
05/08/2003WO2003037400A2 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/08/2003WO2003037370A2 Anthrax antigenic compositions
05/08/2003WO2003037368A2 Smad7 inhibitors for the treatment of cns diseases
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037302A1 Method and system for the co-isolation of cognate dna, rna and protein sequences and method for screening co-isolates for defined activities
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037257A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
05/08/2003WO2003037255A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037247A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037081A1 Hcv gene transgenic animal
05/08/2003WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus
05/08/2003WO2003037079A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE
05/08/2003WO2003037074A2 Methods of generating knock-out rodents
05/08/2003WO2003037072A2 Promotion of somatic embryogenesis in plants by wuschel gene expression
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003025187A3 Improvement of gene expression in vectors
05/08/2003WO2003025138A3 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003022228A9 Method for producing transgenic birds and fish
05/08/2003WO2003020891A3 Single nucleotide amplification and detection by polymerase
05/08/2003WO2003019143A3 Fluorescent multiplex hpv pcr assays using multiple fluorophores
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003010308A3 Control of gene expression
05/08/2003WO2003008629A3 Methods for identification of activators of g protein-coulpled receptors and nucleic acids encoding those receptors
05/08/2003WO2003006649A3 Expression system
05/08/2003WO2003004691A3 Regulators of biofilm formation and uses thereof
05/08/2003WO2003004617A8 Novel human proteins, polynucleotides encoding them and methods of using the same
05/08/2003WO2003003816A3 Methods for enhancing segregation of transgenes in plants and compositions thereof
05/08/2003WO2002100891A3 Proteins derived from non-typable haemophilus influenzae (nthi) strain
05/08/2003WO2002098908A3 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
05/08/2003WO2002098368A3 Mutant forms of cholera holotoxin as an adjuvant
05/08/2003WO2002098286A3 Implantation of biological pacemaker that is molecularly determined
05/08/2003WO2002097114A3 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
05/08/2003WO2002095023A3 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
1 ... 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 ... 4023